• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过两步培养结合钙离子载体处理从脐血和骨髓CD34+细胞生成功能性成熟树突状细胞。

Generation of functional and mature dendritic cells from cord blood and bone marrow CD34+ cells by two-step culture combined with calcium ionophore treatment.

作者信息

Liu Aichun, Takahashi Masuhiro, Narita Miwako, Zheng Zhiyin, Kanazawa Naoko, Abe Takashi, Nikkuni Kohji, Furukawa Tatsuo, Toba Ken, Fuse Ichiro, Aizawa Yoshifusa

机构信息

First Department of Internal Medicine, Faculty of Medicine, Niigata University, Niigata, Japan.

出版信息

J Immunol Methods. 2002 Mar 1;261(1-2):49-63. doi: 10.1016/s0022-1759(01)00545-2.

DOI:10.1016/s0022-1759(01)00545-2
PMID:11861065
Abstract

The object of this study is to explore a culture method to generate a large number of functional and mature dendritic cells (DC) from human CD34+ hematopoietic progenitor cells. In the present study, we used a two-step method combined with calcium ionophore to induce DC from cord blood (CB) or normal human bone marrow (BM) CD34+ progenitor cells. The two-step method consists of 10 days of first step culture for the expansion and proliferation of CD34+ hematopoietic progenitor cells in the presence of SCF, IL-3, IL-6, G-CSF, and 7--11 days of second step culture for the induction of DC in the presence of GM-CSF, IL-4 and TNF-alpha. By the two-step culture, total nucleated cells were increased 208+/-66 (+/-SD, n=13), or 94+/-29 (n=5)-fold in the culture of CB or BM cells, respectively, compared with the number of CD34+ cells at the time of starting culture. Out of the total nucleated cells, 23 +/-10.4% of cells in CB cell culture and 25 +/-5% of cells in the BM cell culture acquired DC characteristic phenotypes, which were marked expressions of CD1a, HLA-DR, co-stimulatory molecules such as CD80, CD40, and adhesion molecule such as CD58. In allogeneic mixed leukocyte reaction (MLR), two-step cultured cells showed potent allo-stimulatory capacity. With this two-step culture, the absolute number of CD1a+ cells that co-expressed HLA-DR, CD80, CD40 and CD58 was enhanced approximately 3 times in CB cell culture and 1.9 times in BM cell culture, compared with the commonly used one-step culture method for the generation of DC from CD34+ cells using SCF, GM-CSF and TNF-alpha. However, on these DC generated in the two-step culture, the expressions of co-stimulatory molecule CD86 and mature DC marker CD83 were not sufficient. By the treatment of two-step cultured cells with calcium ionophore agent (A23187), the expression of co-stimulatory molecules such as CD86 and CD80 (especially CD86) was up-regulated. Besides, the expression of mature DC marker CD83 was remarkably induced by treatment with A23187 for a short duration (24 h). Consistent with the up-regulation of surface molecules CD86, CD80 and CD83, the two-step cultured cells treated with A23187 also showed a stronger allo-stimulatory capacity compared with the cells without A23187 treatment. In conclusion, the present study demonstrated that the two-step culture method effectively improved the yield of CD1a+ DC generated from CD34+ cells, and the phenotypes and functions of these CD1a+ DC could be enhanced efficiently by treatment with a calcium ionophore agent.

摘要

本研究的目的是探索一种培养方法,以从人CD34+造血祖细胞中大量生成功能性成熟树突状细胞(DC)。在本研究中,我们采用两步法并结合钙离子载体,从脐血(CB)或正常人骨髓(BM)CD34+祖细胞诱导生成DC。两步法包括第一步在SCF、IL-3、IL-6、G-CSF存在下培养10天,用于CD34+造血祖细胞的扩增和增殖;第二步在GM-CSF、IL-4和TNF-α存在下培养7-11天,用于诱导DC。通过两步培养,与培养开始时的CD34+细胞数量相比,CB或BM细胞培养物中的总核细胞分别增加了208±66(±SD,n = 13)倍或94±29(n = 5)倍。在总核细胞中,CB细胞培养物中有23±10.4%的细胞以及BM细胞培养物中有25±5%的细胞获得了DC特征性表型,其特征为CD1a、HLA-DR的显著表达,共刺激分子如CD80、CD40以及黏附分子如CD58的表达。在同种异体混合淋巴细胞反应(MLR)中,两步培养的细胞显示出强大的同种异体刺激能力。与使用SCF、GM-CSF和TNF-α从CD34+细胞生成DC的常用一步培养法相比,通过这种两步培养,共表达HLA-DR、CD80、CD40和CD58的CD1a+细胞的绝对数量在CB细胞培养物中增加了约3倍,在BM细胞培养物中增加了1.9倍。然而,在两步培养生成的这些DC上,共刺激分子CD86和成熟DC标志物CD83的表达并不充分。通过用钙离子载体试剂(A23187)处理两步培养的细胞,共刺激分子如CD86和CD80(尤其是CD86)的表达上调。此外,通过短时间(24小时)用A23187处理可显著诱导成熟DC标志物CD83的表达。与表面分子CD86、CD80和CD83的上调一致,用A23187处理的两步培养细胞与未用A23187处理的细胞相比,也显示出更强的同种异体刺激能力。总之,本研究表明两步培养法有效地提高了从CD34+细胞生成的CD1a+ DC的产量,并且通过用钙离子载体试剂处理可有效增强这些CD1a+ DC的表型和功能。

相似文献

1
Generation of functional and mature dendritic cells from cord blood and bone marrow CD34+ cells by two-step culture combined with calcium ionophore treatment.通过两步培养结合钙离子载体处理从脐血和骨髓CD34+细胞生成功能性成熟树突状细胞。
J Immunol Methods. 2002 Mar 1;261(1-2):49-63. doi: 10.1016/s0022-1759(01)00545-2.
2
Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.通过与粒细胞巨噬细胞集落刺激因子、白细胞介素-4和肿瘤坏死因子-α共同培养,从脐血贴壁细胞生成树突状细胞。
J Hematother Stem Cell Res. 2000 Aug;9(4):453-64. doi: 10.1089/152581600419116.
3
In vitro generation of human CD86+ dendritic cells from CD34+ haematopoietic progenitors by PMA and in serum-free medium.在无血清培养基中通过佛波酯(PMA)从CD34⁺造血祖细胞体外生成人CD86⁺树突状细胞。
Clin Exp Immunol. 2001 Aug;125(2):237-44. doi: 10.1046/j.1365-2249.2001.01605.x.
4
Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.从新鲜和冷冻脐血CD34+细胞生成树突状细胞。
Cryobiology. 1998 Dec;37(4):362-71. doi: 10.1006/cryo.1998.2136.
5
Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells.自体血清对CD34(+)或单核细胞来源树突状细胞的不同作用。
J Hematother Stem Cell Res. 2001 Aug;10(4):569-78. doi: 10.1089/15258160152509172.
6
[Comparison of expanding dendritic cells derived from cord blood and mobilized peripheral blood by two-step culture method].[两步培养法扩增脐血与动员外周血来源树突状细胞的比较]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Dec;14(6):1163-7.
7
IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic cell precursors in vitro.白细胞介素-4和CD40连接在体外对人CD34+细胞来源的CD1a+CD14-和CD1a-CD14+树突状细胞前体的分化、成熟及功能有不同影响。
J Leukoc Biol. 1998 Aug;64(2):235-44. doi: 10.1002/jlb.64.2.235.
8
Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells.脐带血来源的CD14+和CD34+树突状细胞的共刺激功能
Exp Mol Pathol. 2003 Aug;75(1):18-33. doi: 10.1016/s0014-4800(03)00034-0.
9
Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.通过白细胞介素-6和白细胞介素-3从CD34+细胞中选择性生成不同的树突状细胞前体。
Stem Cells. 2004;22(5):725-40. doi: 10.1634/stemcells.22-5-725.
10
Efficient generation of CD34+ progenitor-derived dendritic cells from G-CSF-mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment.从粒细胞集落刺激因子(G-CSF)动员的外周单个核细胞高效生成CD34+祖细胞来源的树突状细胞无需富集造血干细胞。
J Leukoc Biol. 2007 Apr;81(4):957-67. doi: 10.1189/jlb.0406296. Epub 2007 Jan 17.

引用本文的文献

1
Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy.脐带血来源的CD11c(+)树突状细胞可作为癌症免疫治疗中树突状细胞的一种异体替代来源。
Stem Cell Res Ther. 2015 Sep 25;6:184. doi: 10.1186/s13287-015-0160-8.
2
Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses.用全肿瘤裂解物冲击的第 4 天骨髓源性树突状细胞具有很强的免疫原性,并能引发有效的抗肿瘤反应。
PLoS One. 2011;6(12):e28732. doi: 10.1371/journal.pone.0028732. Epub 2011 Dec 14.
3
Production of functional dendritic cells from menstrual blood--a new dendritic cell source for immune therapy.
从月经血中制备功能性树突状细胞——免疫治疗的新树突状细胞来源。
In Vitro Cell Dev Biol Anim. 2011 Jun;47(5-6):368-75. doi: 10.1007/s11626-011-9399-2. Epub 2011 Mar 18.
4
Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells.造血干细胞来源的新型树突状细胞系的体外发育、扩增及体内分析
J Immune Based Ther Vaccines. 2010 Nov 24;8:8. doi: 10.1186/1476-8518-8-8.
5
Combination use of immune complexes and a Ca2(+) channel blocker azelnidipine enhances interleukin-12 p40 secretion without T helper type 17 cytokine secretion in human monocyte-derived dendritic cells.免疫复合物与钙离子通道阻滞剂阿折地平联合使用可增强人单核细胞衍生树突状细胞中白细胞介素-12 p40的分泌,而不会分泌17型辅助性T细胞细胞因子。
Clin Exp Immunol. 2009 Jun;156(3):405-12. doi: 10.1111/j.1365-2249.2009.03911.x.
6
What is the future for cord blood stem cells?脐带血干细胞的未来如何?
Cytotechnology. 2003 Mar;41(2-3):133-8. doi: 10.1023/A:1024874706356.
7
Immunisation with 'naïve' syngeneic dendritic cells protects mice from tumour challenge.用“未致敏”的同基因树突状细胞进行免疫可保护小鼠免受肿瘤攻击。
Br J Cancer. 2008 Feb 26;98(4):784-91. doi: 10.1038/sj.bjc.6604221. Epub 2008 Feb 5.